Grundläggande statistik
| Chef | Mark N. Lampert |
| Insiderprofil | BIOTECHNOLOGY VALUE FUND L P |
| Portföljvärde | $ 3 153 742 050 |
| Aktuella positioner | 55 |
| Aktivistpositioner | 37 |
Senaste innehav, resultat, förvaltat kapital (från 13F, 13D)
13D/G-arkiveringar
Detta är en lista över 13D- och 13G-arkiveringar som gjorts under det senaste året (om några). Klicka på länken för att se hela transaktionshistoriken. Gröna rader indikerar nya positioner. Röda rader indikerar stängda positioner.
| Fil Datum | Formulär | Värdepapper | Föregående aktier |
Aktuella aktier |
ΔAktier % | % Ägande |
% ΔÄgande | |
|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | XFOR / X4 Pharmaceuticals, Inc. | 2 258 400 | 2 243 659 | −0,65 | 9,90 | 421,05 | ||
| 2025-08-18 | GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) | 2 438 964 | 9 611 751 | 294,09 | 5,60 | 211,11 | ||
| 2025-08-14 | VIGL / Vigil Neuroscience, Inc. | 4 734 500 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-08-14 | UNCY / Unicycive Therapeutics, Inc. | 1 417 117 | 9,99 | |||||
| 2025-08-14 | VERV / Verve Therapeutics, Inc. | 6 904 050 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-08-14 | CBIO / Crescent Biopharma, Inc. | 0 | 1 387 863 | 9,99 | ||||
| 2025-08-14 | ITOS / iTeos Therapeutics, Inc. | 3 075 000 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-08-14 | IMUX / Immunic, Inc. | 8 902 972 | 9 785 178 | 9,91 | 9,99 | 0,91 | ||
| 2025-08-13 | VSTM / Verastem, Inc. | 4 706 551 | 5 720 831 | 21,55 | 9,99 | 0,00 | ||
| 2025-08-07 | EPIX / ESSA Pharma Inc. | 8 748 629 | 11 668 473 | 33,37 | 24,70 | 25,38 | ||
| 2025-07-21 | OVID / Ovid Therapeutics Inc. | 3 853 818 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-07-09 | NKTR / Nektar Therapeutics | 1 276 595 | 7,40 | |||||
| 2025-07-09 | CTMX / CytomX Therapeutics, Inc. | 8 089 795 | 11 538 462 | 42,63 | 6,80 | −31,93 | ||
| 2025-06-16 | PTGX / Protagonist Therapeutics, Inc. | 2 970 427 | 3 211 041 | 8,10 | 5,20 | 6,12 | ||
| 2025-05-20 | XOMA / XOMA Royalty Corporation | 2 983 026 | 2 590 303 | −13,17 | 21,60 | −14,62 | ||
| 2025-05-19 | ALLK / Allakos Inc. | 16 552 417 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-05-15 | CDTX / Cidara Therapeutics, Inc. | 1 093 499 | 1 252 441 | 14,54 | 9,99 | 0,00 | ||
| 2025-05-15 | GHRS / GH Research PLC | 10 400 158 | 8 827 712 | −15,12 | 14,20 | −28,96 | ||
| 2025-05-15 | FDMT / 4D Molecular Therapeutics, Inc. | 4 834 297 | 4 632 749 | −4,17 | 9,99 | 0,00 | ||
| 2025-05-15 | ELEV / Elevation Oncology, Inc. | 6 230 845 | 4 440 000 | −28,74 | 7,00 | −29,93 | ||
| 2025-05-15 | GLUE / Monte Rosa Therapeutics, Inc. | 4 393 210 | 5 660 132 | 28,84 | 9,20 | 27,78 | ||
| 2025-05-15 | SEPN / Septerna, Inc. | 2 452 024 | 4 396 124 | 79,29 | 9,90 | 80,00 | ||
| 2025-05-15 | TCRX / TScan Therapeutics, Inc. | 5 073 003 | 5 263 541 | 3,76 | 9,99 | 0,00 | ||
| 2025-05-09 | IVA / Inventiva S.A. - Depositary Receipt (Common Stock) | 8 545 499 | 8 545 499 | 0,00 | 6,10 | −32,22 | ||
| 2025-04-16 | THRD / Third Harmonic Bio, Inc. | 2 372 933 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2025-02-14 | FBRX / Forte Biosciences, Inc. | 2 982 105 | 643 622 | −78,42 | 9,99 | 21,83 | ||
| 2025-02-14 | ETNB / 89bio, Inc. | 6 811 631 | 4 333 885 | −36,38 | 3,60 | −43,75 | ||
| 2025-02-14 | AVTX / Avalo Therapeutics, Inc. | 967 299 | 1 038 542 | 7,37 | 9,99 | 0,00 | ||
| 2025-02-14 | TYRA / Tyra Biosciences, Inc. | 4 661 194 | 3 944 194 | −15,38 | 7,80 | −11,36 | ||
| 2025-02-14 | VTGN / Vistagen Therapeutics, Inc. | 2 777 245 | 3 084 324 | 11,06 | 9,97 | −0,20 | ||
| 2025-02-14 | IKNA / Ikena Oncology, Inc. | 4 769 164 | 4 006 564 | −15,99 | 8,30 | −16,16 | ||
| 2025-02-04 | KURA / Kura Oncology, Inc. | 4 212 346 | 5 912 554 | 40,36 | 7,50 | 38,89 | ||
| 2025-01-29 | ENGN / enGene Holdings Inc. | 3 196 439 | 945 402 | −70,42 | 1,80 | −75,00 | ||
| 2025-01-06 | RAPT / RAPT Therapeutics, Inc. | 11 764 000 | 8,70 | |||||
| 2024-12-17 | PVLA / Palvella Therapeutics, Inc. | 1 168 117 | 9,99 | |||||
| 2024-12-04 | OLMA / Olema Pharmaceuticals, Inc. | 9 135 893 | 7 557 237 | −17,28 | 9,99 | −40,18 | ||
| 2024-11-14 | MTEM / Molecular Templates, Inc. | 537 426 | 672 767 | 25,18 | 9,99 | 0,00 | ||
| 2024-11-14 | ACIU / AC Immune SA | 14 571 236 | 19 522 436 | 33,98 | 19,70 | 33,11 | ||
| 2024-11-14 | VIRX / Viracta Therapeutics, Inc. | 3 833 785 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | LXRX / Lexicon Pharmaceuticals, Inc. | 24 435 632 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | STRO / Sutro Biopharma, Inc. | 3 347 946 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | RGLS / Regulus Therapeutics Inc. | 9 661 235 | 883 844 | −90,85 | 1,30 | −86,99 | ||
| 2024-11-14 | ANTX / AN2 Therapeutics, Inc. | 1 563 963 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | ZYME / Zymeworks Inc. | 5 870 000 | 4 607 935 | −21,50 | 6,50 | −30,11 | ||
| 2024-11-14 | CGEM / Cullinan Therapeutics, Inc. | 4 393 321 | 5 796 433 | 31,94 | 9,99 | 0,00 | ||
| 2024-11-14 | JANX / Janux Therapeutics, Inc. | 4 579 818 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | IDYA / IDEAYA Biosciences, Inc. | 3 479 043 | 1 409 993 | −59,47 | 1,70 | −67,92 | ||
| 2024-11-14 | DCTH / Delcath Systems, Inc. | 2 338 426 | 1 041 667 | −55,45 | 3,60 | −63,96 | ||
| 2024-11-14 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 8 774 570 | 0 | −100,00 | 0,00 | −100,00 | ||
| 2024-11-14 | ANNX / Annexon, Inc. | 7 000 000 | 9 027 778 | 28,97 | 8,40 | −5,62 | ||
| 2024-11-14 | MIRM / Mirum Pharmaceuticals, Inc. | 4 370 024 | 3 075 907 | −29,61 | 6,40 | −31,91 | ||
| 2024-10-31 | ELDN / Eledon Pharmaceuticals, Inc. | 4 326 710 | 6 293 282 | 45,45 | 10,50 | −41,34 | ||
| 2024-10-29 | MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) | 8 696 205 | 9 888 592 | 13,71 | 24,50 | 2,51 | ||
| 2024-10-08 | MLTX / MoonLake Immunotherapeutics | 21 751 284 | 19 751 284 | −9,19 | 31,40 | −9,25 | ||
| 2024-09-11 | CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) | 6 260 311 | 0 | −100,00 | 0,00 | −100,00 |
